SCHEMBL29351

SCHEMBL29351

[CH2]CCCCCCCCCC[CH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6682668 1.00
SCHEMBL27960 1.00
SCHEMBL133577 1.00
SCHEMBL1548872 1.00
SCHEMBL1548917 1.00
SCHEMBL1548258 1.00
SCHEMBL135762 1.00
SCHEMBL1548280 1.00
SCHEMBL153008 1.00
SCHEMBL28775 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 19272 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118265692-A Carbon nucleus cationic lipid 厦门赛诺邦格生物科技股份有限公司 2024-06-28 CN claimed
US-20240197633-A1 PEGYLATED LIPID, LIPOSOME MODIFIED BY THE LIPID, PHARMACEUTICAL COMPOSITION CONTAINING THE LIPOSOME, FORMULATION AND APPLICATION THEREOF XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2024-06-20 US claimed
US-20240190883-A1 KRAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2024-06-13 US claimed
WO-2024120442-A1 PAK4 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS CONVERGEN (SUZHOU) PHARMACEUTICAL CO., LTD. (CN) 2024-06-13 WO claimed
US-20240180951-A1 PEGYLATED LIPID, LIPOSOME MODIFIED BY THE LIPID, PHARMACEUTICAL COMPOSITION CONTAINING THE LIPOSOME, FORMULATION AND APPLICATION THEREOF XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2024-06-06 US claimed
CN-115197078-B Pegylated lipid and modified liposome thereof, pharmaceutical composition containing liposome and preparation and application of pharmaceutical composition 厦门赛诺邦格生物科技股份有限公司 2024-06-04 CN claimed
US-20240174643-A1 SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2024-05-30 US claimed
CN-113980645-B Gap filler composition, use thereof, and workpiece joint body prepared therefrom 南京德普瑞克环保科技股份公司 2024-05-14 CN claimed
EP-3898737-B1 AQUEOUS PRIMER COATING COVESTRO DEUTSCHLAND AG (DE) 2024-05-08 EP claimed
EP-3672961-B1 RENEWABLE HIGHLY BIOBASED POLYBENZOXAZINE THERMOSETS FOR COMPOSITE APPLICATIONS UNIV DREXEL (US) 2024-05-01 EP claimed
EP-0094343-A1 Polyalkylpiperidine derivatives containing isocyanate groups CIBA-GEIGY AG (CH) 1983-11-16 EP claimed
EP-0030822-B1 SYNTHETIC ABSORBABLE SURGICAL DEVICES OF POLYESTER AMIDES AND PROCESS FOR MAKING THEM MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1983-09-14 EP claimed
US-4343931-A FILAMENTS, SUTURES, PROSTHETICS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1982-08-10 US claimed
EP-0053937-A1 Polynuclear fused aromatic ring type polymer and preparation thereof Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1982-06-16 EP claimed
US-4278791-A CORROSION RESISTANCE, WETTING AGENTS BAYER AKTIENGESELLSCHAFT (DE) 1981-07-14 US claimed
EP-0030822-A2 Synthetic absorbable surgical devices of polyester amides and process for making them MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1981-06-24 EP claimed
EP-0023569-A1 Derivatives of carboxylic acids, their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1981-02-11 EP claimed
US-4247474-A POLYFUNCTIONAL ALKYLENE, CYCLOALKYLENE, OR ARYLENE DERIVATIVES; HYDROGEN CHLORIDE SALTS USED AS CURING AGENTS HERCULES INCORPORATED (US) 1981-01-27 US claimed
US-4171374-A 1-ARYLOXY-3-SUBSTITUTED UREIDO-ALKYLAMINO-2-PROPANOLS, ADRENERGIC BLOCKING AGENTS, CARDIAC STIMULANTS IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1979-10-16 US claimed
US-3995054-A MITICIDES ZOECON CORPORATION (US) 1976-11-30 US claimed